A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment
Clinical trial NCT06352528 · COMPLETED
Trial details
- NCT number
- NCT06352528
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-29
- Primary completion
- 2025-09-16
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.